Skip to content
healthcare.dev

Repaglinide

NDC 72603-811, Repaglinide, tablet, from NorthStar RxLLC.

Product NDC
72603-811
Status
Listed
Labeler
NorthStar RxLLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207209
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72603-811 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REPAGLINIDE1 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
72603-811-0172603081101100 TABLET in 1 BOTTLE (72603-811-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665
  • NADAC price for package 72603081101

    GET /v1/drugs/nadac/72603081101

Use it

Look up 72603-811 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72603-811 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72603-811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.